Image (577be450 71e7 4864 87f2 Daf2fc004082 01)
Fenofibrate Tablet, Film Coated
Product Images NDC 42385-935
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 42385-935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (577be450 71e7 4864 87f2 Daf2fc004082 02)
Each film-coated tablet contains 54 mg of fenofibrate and is prescribed for adults. The usual dosage and prescribing information can be found in the packaging insert. The medication should be stored at room temperature and protected from moisture. It should also be kept out of the reach of children and dispensed only in a child-resistant container. Manufactured by Graviti Pharmaceuticals Pvt. Ltd in India and distributed by LAURUS Labs.*
Image (577be450 71e7 4864 87f2 Daf2fc004082 03)
Fenofibrate Tablets contain 160mg of fenofibrate. They should be stored in a tight, light-resistant container at room temperature and protected from moisture. The tablets are prescription only and should be kept out of reach of children. The manufacturer is Laurus Generics Inc, and they were manufactured by Graviti Pharmaceuticals, Py Ltd in Telangana, India. Dosage instructions should be obtained from the package insert. The NDC number is 42385-936-90. There is additional unreadable text at the end.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
